PTK7 and breast cancer: Current clinical trials of BC are combining gedatolisib with a range of other therapies, including herzuma (NCT03698383), PTK7-ADC (NCT03243331), palbociclib (NCT02626507 and NCT02684032), fulvestrant and letrozole (NCT02684032), and cisplatin and docetaxel (NCT01920061) (ClinicalTrials.gov, accessed on 7 December 2020).